Boston, MA2 Active Studies

IgA Nephropathy Clinical Trials in Boston, MA

Find 2 actively recruiting iga nephropathy clinical trials in Boston, MA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
994
Enrolling

Recruiting IgA Nephropathy Studies in Boston

About IgA Nephropathy Clinical Trials in Boston

IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.

There are currently 2 iga nephropathy clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 994 participants. Research is being sponsored by Novartis Pharmaceuticals, Biogen. Clinical trial participation is free and participants receive study-related medical care at no cost.

IgA Nephropathy Clinical Trials in Boston — FAQ

Are there iga nephropathy clinical trials in Boston?

Yes, there are 2 iga nephropathy clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What iga nephropathy treatments are being tested?

The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.

Data updated March 2, 2026 from ClinicalTrials.gov